| Simagchem Corporation | China | Inquire | ||
|---|---|---|---|---|
![]() | www.simagchem.com | |||
![]() | +86 13806087780 | |||
![]() | +86 (592) 268-0237 | |||
![]() | sale@simagchem.com | |||
| Chemical manufacturer since 2002 | ||||
| chemBlink Standard supplier since 2008 | ||||
| Zhejiang Chemline industries Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.chinachemline.com | |||
![]() | +86 (571) 8720-7757 | |||
![]() | +86 (571) 8806-2298 | |||
![]() | chemline_08@hotmail.com 360759612@qq.com | |||
| Chemical distributor since 2004 | ||||
| chemBlink Standard supplier since 2009 | ||||
| Hefei TNJ Chemical Industry Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.tnjchem.com | |||
![]() | +86 (551) 6541-8684 | |||
![]() | +86 (551) 6541-8697 | |||
![]() | sales@tnjchem.com | |||
| Chemical manufacturer since 2001 | ||||
| chemBlink Standard supplier since 2010 | ||||
| Hangzhou Cherry Pharmaceutical Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.cherrypharmatech.com | |||
![]() | +86 (571) 8163-6070 +86 18042403330 | |||
![]() | +86 (571) 8163-6070 | |||
![]() | info@cherrypharmatech.com | |||
![]() | QQ Chat | |||
![]() | Skype Chat | |||
| Chemical manufacturer since 2015 | ||||
| chemBlink Standard supplier since 2015 | ||||
| ECA International Corporation | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.ecacorporation.com | |||
![]() | +1 (847) 358-8178 | |||
![]() | +1 (847) 358-8179 | |||
![]() | order@ecacorporation.com | |||
| Chemical manufacturer | ||||
| Classification | API >> Synthetic anti-infective drugs >> Antifungal drugs |
|---|---|
| Name | Sulfaquinoxaline sodium |
| Synonyms | N'1-Quinoxalin-2-ylsulphanilamide sodium salt |
| Molecular Structure | ![]() |
| Molecular Formula | C14H11N4NaO2S |
| Molecular Weight | 322.32 |
| CAS Registry Number | 967-80-6 |
| EC Number | 213-526-2 |
| Hazard Symbols | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R22;R42/43 Details | ||||||||||||||||||||
| Safety Statements | S22;S36/37;S45 Details | ||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||
| |||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Sulfaquinoxaline sodium |